Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.330
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Mar 9, 2026, 6:57 PM EDT
Fate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 155 | 113 | 188 | 369 | 980 | 5,587 | |
| Market Cap Growth | -12.14% | -39.69% | -49.04% | -62.39% | -82.45% | -29.57% | |
| Enterprise Value | 29 | -23 | -10 | 124 | 586 | 5,018 | |
| Last Close Price | 1.33 | 0.98 | 1.65 | 3.74 | 10.09 | 58.51 | |
| PS Ratio | 23.27 | 17.06 | 13.79 | 5.80 | 10.18 | 100.05 | |
| PB Ratio | 0.74 | 0.55 | 0.59 | 1.00 | 2.03 | 8.23 | |
| P/TBV Ratio | 0.75 | 0.55 | 0.59 | 1.00 | 2.03 | 8.23 | |
| EV/Sales Ratio | 4.34 | - | - | 1.95 | 6.09 | 89.85 | |
| Debt / Equity Ratio | 0.38 | 0.38 | 0.27 | 0.28 | 0.23 | 0.17 | |
| Net Debt / Equity Ratio | -0.61 | -0.61 | -0.61 | -0.57 | -0.67 | -0.74 | |
| Net Debt / EBITDA Ratio | 0.94 | 0.94 | 1.10 | 1.23 | 1.11 | 2.37 | |
| Net Debt / FCF Ratio | 1.12 | 1.12 | 1.57 | 1.53 | 1.15 | 2.35 | |
| Asset Turnover | 0.02 | 0.02 | 0.03 | 0.11 | 0.12 | 0.07 | |
| Quick Ratio | 5.69 | 5.69 | 7.39 | 8.13 | 4.17 | 7.70 | |
| Current Ratio | 5.79 | 5.79 | 7.58 | 8.48 | 4.40 | 7.79 | |
| Return on Equity (ROE) | -51.84% | -51.84% | -54.21% | -37.76% | -48.46% | -39.91% | |
| Return on Assets (ROA) | -24.12% | -24.12% | -25.81% | -19.65% | -23.69% | -17.57% | |
| Return on Capital Employed (ROCE) | -51.80% | -51.80% | -48.60% | -40.80% | -52.10% | -25.80% | |
| Earnings Yield | -88.16% | -120.27% | -99.11% | -43.64% | -28.73% | -3.80% | |
| FCF Yield | -72.45% | -98.85% | -65.77% | -37.53% | -28.94% | -3.82% | |
| Buyback Yield / Dilution | -4.49% | -4.49% | -15.52% | -1.64% | -2.19% | -15.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.